| ||
Lupin identifies cancer drugs as focus area in Japan Economic Times ... company, which is present in Japan through two wholly -owned subsidiaries - Kyowa Pharmaceutical Industry and I'rom Pharmaceuticals - has created a product basket of about 7-8 oncology products there through a mix of in-licensing and co-development. See all stories on this topic » | ||
New psychiatric drugs low priority for pharmaceutical firms CBC.ca The pharmaceutical industry has largely abandoned drug development for mental illnesses even though depression is a leading cause of disability, experts say. Authors of papers published in this week's issue of the journal Science Translational Medicine ... See all stories on this topic » | ||
Intercept Pharmaceuticals: Strong Biopharmaceutical IPO Seeking Alpha Incercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver disease using the company's expertise in bile acid chemistry. The company had a lead product ... See all stories on this topic » | ||
5 Top Pharmaceuticals Paying Substantial Dividends Seeking Alpha Despite accelerating pressures due to uncertain regulatory reforms, the U.S. pharmaceutical industry remains a major engine of economic growth. This sector includes 3,810 companies with combined annual revenue of $209 billion. For 2012, the sale of ... See all stories on this topic » | ||
| ||
Ignoring the obvious Ocala The agency's concern was that, unlike big pharmaceutical companies that must meet exacting federal tolerances for the drugs they dispense and the manner by which they create them, small compounding labs are barely regulated at all. The reason is that, ... See all stories on this topic » | ||
| ||
Indonesia Acts to Override Patents on HIV Drugs Jakarta Globe Indonesia's government has taken steps to override patents on a range of HIV drugs, highlighting a growing trend by Asian states to allow local production of cheap generic drugs that cut into sales of global pharmaceutical companies. President Susilo ... See all stories on this topic » | ||
Teva inaugurates large sterile medicine plant in Hungary Globes Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has opened a new plant in Hungary. The $110 million plant in Gödöllő, is one of the largest sterile medicines plants in the world. The plant has an annual production capacity of 160-200 ... See all stories on this topic » | ||
Medicare information sessions offered as open enrollment begins Rochester Democrat and Chronicle With open enrollment beginning Monday and running through Dec. 7, Lifespan is offering its annual Medicare 101 information sessions. The workshops also include an explanation of changes to New York state's Elderly Pharmaceutical Insurance Coverage. See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment